Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Risk factor prediction and immune correlation analysis of cuproptosis-related gene in osteoarthritis. | J Cell Mol Med | 2024 | 39087591 | PubTator, text mining | PubMed |
| Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy? | Cell Commun Signal | 2024 | 39068453 | PubTator, text mining | PubMed |
| Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells. | Cancer Med | 2024 | 39031012 | PubTator, text mining | PubMed |
| Stoichiometry and architecture of the human pyruvate dehydrogenase complex. | Sci Adv | 2024 | 39018392 | PubTator, text mining | PubMed |
| Carbamazepine responsive episodic dystonia and hallucination due to pyruvate dehydrogenase E2 (DLAT) gene mutation. | J Neurogenet | 2024 | 39007626 | PubTator, text mining | PubMed |
| Copper-Based Composites Nanoparticles Improve Triple-Negative Breast Cancer Treatment with Induction of Apoptosis-Cuproptosis and Immune Activation. | Adv Healthc Mater | 2024 | 39001628 | PubTator, text mining | PubMed |
| A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomas. | Heliyon | 2024 | 38961981 | PubTator, text mining | PubMed |
| Copper redox state in cells and aquatic organisms: Implication for toxicity. | J Hazard Mater | 2024 | 38941830 | PubTator, text mining | PubMed |
| Identification of potential crucial cuproptosis-related genes in myocardial ischemia-reperfusion injury through the bioinformatic analysis. | Clinics (Sao Paulo) | 2024 | 38901133 | PubTator, text mining | PubMed |
| Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer. | Imeta | 2024 | 38898987 | PubTator, text mining | PubMed |
| Helicobacter Pylori-Enhanced hnRNPA2B1 Coordinates with PABPC1 to Promote Non-m6A Translation and Gastric Cancer Progression. | Adv Sci (Weinh) | 2024 | 38887155 | PubTator, text mining | PubMed |
Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes. | Front Immunol | 2024 | 38868777 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the role of cuproptosis gene in acute myocardial infarction. | Minerva Cardiol Angiol | 2024 | 38842240 | PubTator, text mining | PubMed |
| Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation. | J Hepatol | 2024 | 38821360 | PubTator, text mining | PubMed |
| Who follows through? Different factors predict initial commitment vs. Following through in a national survey of organ donor registration. | PLoS One | 2024 | 38809885 | PubTator, text mining | PubMed |
| Investigating hub genes in the relationship between septic cardiomyopathy and cuproptosis and potential Chinese herbal drug candidates with bioinformatic tools. | Minerva Cardiol Angiol | 2024 | 38804624 | PubTator, text mining | PubMed |
| Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA. | Technol Cancer Res Treat | 2024 | 38802999 | PubTator, text mining | PubMed |
| Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes. | Front Immunol | 2024 | 38799437 | PubTator, text mining | PubMed |
| Probiotic functional gene explorations in the genome of Limosilactobacillus fermentum GD5MG. | Microb Pathog | 2024 | 38750775 | PubTator, text mining | PubMed |
| Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes. | Biomed Pharmacother | 2024 | 38733771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=19